Dr Reddys Laboratories (RDY) Interest & Investment Income (2013 - 2025)

Dr Reddys Laboratories' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $23.7 million for Q4 2025.

• In Q4 2025, Interest & Investment Income fell 55.94% year-over-year to $23.7 million; the TTM figure through Dec 2025 stood at $23.7 million (down 55.94% YoY), while the FY2026 annual figure was $84.0 million, down 4.55% from the prior year.
• Interest & Investment Income was $23.7 million for Q4 2025 at Dr Reddys Laboratories, up from -$3.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $53.8 million in Q4 2024 to a low of -$12.8 million in Q1 2022.
• Historically, Interest & Investment Income has averaged $12.0 million across 5 years, with a median of $5.4 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 205.09% in 2022, then plunged 438.8% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at -$6.0 million in 2021, then increased by 9.77% to -$5.4 million in 2022, then surged by 1004.44% to $49.1 million in 2023, then climbed by 9.59% to $53.8 million in 2024, then sank by 55.94% to $23.7 million in 2025.
• The last three Interest & Investment Income figures came in at $23.7 million (Q4 2025), -$3.5 million (Q3 2025), and -$3.5 million (Q2 2025), per Business Quant data.